MedDRA Blue Ribbon Panel

Welcome to the MedDRA Blue Ribbon Panel area. Blue Ribbon Panels (BRPs) have been developed to provide a forum for MedDRA experts from industry and regulatory authorities to discuss and make recommendations on challenging MedDRA issues on behalf of the user community.

BRPs are scheduled based on interest in developing areas related to MedDRA. Panel members are chosen and BRPs are open to subscribers who wish to attend as audience members (observers).

As always, the MSSO appreciates feedback and suggestions for future Blue Ribbon Panel topics.

BRP6 Extent of MedDRA Versioning and Feasibility of an Annual MedDRA Release

This meeting took place on 13 May 2009 at Schering-Plough Corporation, Kenilworth, NJ, USA. The topics of this day-long meeting were: 1. discussion of a draft document by MSSO describing the extent of MedDRA version updating processes and 2. the feasibility of a once-a-year release of MedDRA. The Panel's recommendations were reviewed and endorsed by the MedDRA Management Board.

Meeting Agenda

Background Documents

Extent of versioning: background and questions for Panel
MSSO draft recommendation on Extent of Versioning
Frequency of MedDRA release: background and questions for Panel

BRP Presentation

MedDRA Blue Ribbon Panel on Extend of Versioning and Feasibility of Annual Release

Panel Members

Barry Hammond (GlaxoSmithKline)
JoAnn Medbery (Johnson&Johnson)
Tom Paternoster (EMA)
Toni Piazza-Hepp (FDA)
Yasuo Sakurai (Japanese Maintenance Organization)

BRP 6 Recommendations

Blue Ribbon Panel Archive